TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18410408

Group type: EXPERIMENTAL
Intervention: Etanercept 25 mg twice weekly
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Oral acitretin 0.4 mg kg(‐1) daily
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Etanercept 25 mg once weekly plus acitretin 0.4 mg kg(‐1) daily
Number of subjects: 60
Study: 16338779

Group type: EXPERIMENTAL
Intervention: Butoconazole nitrate 2% Site Release vaginal cream
Number of subjects: 181

Group type: COMPARATOR
Intervention: Fluconazole 150 mg tablets
Number of subjects: 181
Study: 12017904

Group type: EXPERIMENTAL
Intervention: Tramadol 50 mg, as a single dose, administered either 2 hours prior or immediately before the surgical procedure
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Tramadol 50 mg
Number of subjects: 15
Study: 10450625

Group type: EXPERIMENTAL
Intervention: Fluoxetine (30 or 60 mg daily)
Number of subjects: 253

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 253
Study: 7796794

Group type: EXPERIMENTAL
Intervention: HIGH stimulation
Number of subjects: 16

Group type: COMPARATOR
Intervention: LOW stimulation
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both HIGH and LOW stimulation
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: After 9 months of VNS
Number of subjects: 16
Study: 2241443

Group type: EXPERIMENTAL
Intervention: Asymptomatic cerebral infarction in patients with nonvalvular atrial fibrillation
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Asymptomatic cerebral infarction in patients older than 65 years with a left atrial diameter greater than 5.0 cm
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Asymptomatic cerebral infarction in patients younger than 65 years with a left atrial diameter less than 5.0 cm
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Asymptomatic cerebral infarction in patients with only one risk factor (age or left atrial diameter)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Chronic nonvalvular atrial fibrillation
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Intermittent nonvalvular atrial fibrillation
Number of subjects: 141
Study: 464564

Group type: EXPERIMENTAL
Intervention: Erythromycin
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Rosamicin
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study: 30325445

Group type: COMPARATOR
Intervention: Diet with 0.096% Trp
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Diet with 0.116% Trp
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Diet with 0.136% Trp
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Diet with 0.156% Trp
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Diet with 0.176% Trp
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Diet with 0.196% Trp
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Linear broken line model
Number of subjects: 270
Study: 28794253

Group type: EXPERIMENTAL
Intervention: Midodrine only
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Pyridostigmine only
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Midodrine + Pyridostigmine
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 87
Study: 25951410

Group type: EXPERIMENTAL
Intervention: Eating marshmallows (3 marshmallows three times daily)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Eating marshmallows
Number of subjects: 28
Study: 23157581

Group type: EXPERIMENTAL
Intervention: Topiramate (3-25 mg/kg/day)
Number of subjects: 55
Study: 22195380

Group type: EXPERIMENTAL
Intervention: Atraumatic Restorative Treatment (ART) restorations with conditioners (GC Dentine Conditioner)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Atraumatic Restorative Treatment (ART) restorations without conditioners
Number of subjects: 186
Study: 18982338

Group type: EXPERIMENTAL
Intervention: Verum acupuncture
Number of subjects: 123

Group type: COMPARATOR
Intervention: NSAID (diclofenac 3 x 50 mg oral)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Non-specific control points (acupuncture)
Number of subjects: 123
Study: 17003602

Group type: EXPERIMENTAL
Intervention: Endurance-based PR program plus resistance training (RT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Endurance-based PR program (ET)
Number of subjects: 20
Study: 15991780

Group type: EXPERIMENTAL
Intervention: Nurse-delivered intervention including tailored information, assessment of withdrawal, offer of nicotine replacement therapy, booklets, and a discharge letter.
Number of subjects: 1422

Group type: COMPARATOR
Intervention: Control group (standard care).
Number of subjects: 1422
Study: 12630068

Group type: EXPERIMENTAL
Intervention: Complete testosterone suppression therapy
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 21
Study: 9527278

Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO) administered intravenously after dialysis
Number of subjects: 15

Group type: COMPARATOR
Intervention: Normal saline (placebo) administered intravenously after dialysis
Number of subjects: 15
Study: 7885125

Group type: EXPERIMENTAL
Intervention: Cotrimoxazole (160 mg trimethoprim, 800 mg sulphamethoxazole)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 2221512

Group type: EXPERIMENTAL
Intervention: IV metoclopramide 10 mg
Number of subjects: 50

Group type: COMPARATOR
Intervention: IV normal saline (Control)
Number of subjects: 50
Study: 390339

Group type: EXPERIMENTAL
Intervention: Timolol administered once a day
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Timolol administered twice a day
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Timolol combined with a diuretic
Number of subjects: 15
Study: 30836637

Group type: EXPERIMENTAL
Intervention: Diet-induced weight loss after 12 weeks (NAFLD: 4.8 ± 0.5%, No NAFLD: 5.1 ± 0.5%)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Diet-induced weight loss after 50 weeks (NAFLD: 3.5 ± 0.7%, No NAFLD: 3.5 ± 0.9%)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Decrease in liver fat after 12 weeks (NAFLD: 32.9 ± 9.5%, No NAFLD: 6.3 ± 4.0%)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Decrease in liver fat after 50 weeks (NAFLD: 23.3 ± 4.4%, No NAFLD: 5.0 ± 4.2%)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Decreases in biomarkers of liver dysfunction (GGT, ALT, AST)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: HOMA IR
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Other metabolic parameters
Number of subjects: 143
Study: 28654628

Group type: EXPERIMENTAL
Intervention: CE 0.45 mg/BZA 20 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CE 0.625 mg/BZA 20 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 0
Study: 26511146

Group type: EXPERIMENTAL
Intervention: Aliskiren
Number of subjects: 7063

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 7063
Study: 24025377

Group type: EXPERIMENTAL
Intervention: PPD-S
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Measurement at 72 h
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: PPD-S with ballpoint pen-ruler
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Palpation+ruler at 72 h
Number of subjects: 78
Study: 21832297

Group type: EXPERIMENTAL
Intervention: Bicycling (increased by 10 km/week)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Walking
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Bicycling
Number of subjects: 98
Study: 19232615

Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy (n=121)
Number of subjects: 240
Study: 17082957

Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study: 15239792

Group type: COMPARATOR
Intervention: 1.5 mg/day molecular iodine for 6 months
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: 3.0 mg/day molecular iodine for 6 months
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: 6.0 mg/day molecular iodine for 6 months
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study: 11699043

Group type: EXPERIMENTAL
Intervention: Offsprings of NIDDM parents
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Offsprings of NIDDM parents during bed rest
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Offsprings of NIDDM parents in head-up position
Number of subjects: 40
Study: 9042633

Group type: EXPERIMENTAL
Intervention: Active bed covering system
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo bed covering system
Number of subjects: 31
Study: 8192112

Group type: EXPERIMENTAL
Intervention: Allopurinol mouthwashes
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 3285838

Group type: EXPERIMENTAL
Intervention: bromocriptine (2.5-30 mg/d)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: pergolide (50-500 micrograms/d)
Number of subjects: 16
Study: 30771492

Group type: EXPERIMENTAL
Intervention: HPV positive FSWs
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: HIV positive FSWs
Number of subjects: 436
Study: 30100127

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Usual care and workshop on healthy lifestyle
Number of subjects: 79
Study: 26898135

Group type: EXPERIMENTAL
Intervention: Endoscopic Combined Intra‐Renal Surgery (ECIRS)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Minimally Percutaneous Nephrolithotomy (MPCNL)
Number of subjects: 67
Study: 24768981

Group type: EXPERIMENTAL
Intervention: Intravaginal misoprostol, 400 μg, with 100 mL of 5% intravenous glucose (misoprostol arm)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Intravenous ketoprofen, 50 mg/mL, in 100 mL 5% glucose with intravaginal placebo (ketoprofen arm)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Vaginal placebo tablets, 100 mL 5% intravenous glucose (placebo arm)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 150
Study: 23140480

Group type: EXPERIMENTAL
Intervention: Intervention group (up to 12 group sessions over six weeks)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Intervention sessions attended
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 75
Study: 21073062

Group type: EXPERIMENTAL
Intervention: 2PE preserved hepatitis B vaccine kept on the shelf <12 months (2PE New group)
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: 2PE preserved hepatitis B vaccine kept on the shelf >18 months (2PE Old group)
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: Thiomersal preserved hepatitis B vaccine [HBV(Thio) group]
Number of subjects: 420

Group type: COMPARATOR
Intervention: 2PE New and 2PE Old groups
Number of subjects: 420

Group type: COMPARATOR
Intervention: 2PE groups
Number of subjects: 420

Group type: COMPARATOR
Intervention: 2PE New and Old groups
Number of subjects: 420

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: 2PE preserved hepatitis B vaccine
Number of subjects: 420
Study: 17975184

Group type: EXPERIMENTAL
Intervention: Provider communication behaviors (including probing, open-ended opportunities to talk, and responsiveness to patient clues) during screening for domestic violence
Number of subjects: 1281

Group type: EXPERIMENTAL
Intervention: Provider screening for domestic violence
Number of subjects: 1281

Group type: EXPERIMENTAL
Intervention: Chart documentation of domestic violence
Number of subjects: 1281
Study: 17166386

Group type: EXPERIMENTAL
Intervention: Injection Yiyoutasai (75 mg/m², every 3 weeks)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Injection Aisu (75 mg/m², every 3 weeks)
Number of subjects: 67
Study: 12003456

Group type: EXPERIMENTAL
Intervention: Problem-solving therapy
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 9465815

Group type: EXPERIMENTAL
Intervention: Oxytocin induction (n = 57)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Observation (n = 63)
Number of subjects: 120
Study: 8552852

Group type: EXPERIMENTAL
Intervention: One-day seminar on screening for breast cancer and cervical cancer
Number of subjects: 278

Group type: COMPARATOR
Intervention: Control group (no seminar)
Number of subjects: 278
Study: 2203467

Group type: EXPERIMENTAL
Intervention: Antibiotic plus steroid
Number of subjects: 40

Group type: COMPARATOR
Intervention: Antibiotic only
Number of subjects: 40
Study: 870388

Group type: EXPERIMENTAL
Intervention: Infusions of dextran
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Low-dose subcutaneous heparin
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Postoperative oral anticoagulation with cumarins
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Aescin
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group (no drug prophylaxis)
Number of subjects: 8
Study: 31162492

Group type: EXPERIMENTAL
Intervention: Turbinoplasty during septo- or septorhinoplasty
Number of subjects: 73

Group type: COMPARATOR
Intervention: No turbinoplasty during septo- or septorhinoplasty
Number of subjects: 73
Study: 28753102

Group type: EXPERIMENTAL
Intervention: Probiotic yogurt with Bifidobacterium animalis subsp. lactis DN‐173010
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo yogurt
Number of subjects: 51
Study: 27116918

Group type: EXPERIMENTAL
Intervention: Varenicline (1 mg twice a day)
Number of subjects: 8144

Group type: EXPERIMENTAL
Intervention: Bupropion (150 mg twice a day)
Number of subjects: 8144

Group type: EXPERIMENTAL
Intervention: Nicotine patch (21 mg per day with taper)
Number of subjects: 8144

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8144

Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 8144

Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 8144

Group type: EXPERIMENTAL
Intervention: Nicotine patch
Number of subjects: 8144
Study: 24725169

Group type: EXPERIMENTAL
Intervention: 0.4 mg tamsulosin (two tablets of 0.2 mg once daily)
Number of subjects: 220

Group type: COMPARATOR
Intervention: 0.2 mg tamsulosin (one tablet of 0.2 mg and one tablet of placebo once daily)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: 0.4 mg tamsulosin
Number of subjects: 220

Group type: COMPARATOR
Intervention: 0.2 mg tamsulosin
Number of subjects: 220
Study: 22858560

Group type: EXPERIMENTAL
Intervention: Individualised sensitivity elimination dose
Number of subjects: 96

Group type: COMPARATOR
Intervention: Standardised 15 min dose
Number of subjects: 96
Study: 19328636

Group type: EXPERIMENTAL
Intervention: 900 mg St John's wort (SJW) active
Number of subjects: 143

Group type: COMPARATOR
Intervention: Placebo for St John's wort
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: 400 microm chromium active
Number of subjects: 143

Group type: COMPARATOR
Intervention: Placebo for chromium
Number of subjects: 143
Study: 17127698

Group type: EXPERIMENTAL
Intervention: Short induction therapy with anti-thymoglobulin (ATG) and steroids for 4 days, followed by CellCept and tacrolimus
Number of subjects: 24
Study: 15894902

Group type: EXPERIMENTAL
Intervention: Amlodipine (5 mg for 4 weeks followed by 10 mg for 4 weeks, n = 22)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Telmisartan (80 mg for 8 weeks, n = 18)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Ramipril (2.5 mg for 1 week, 5.0 mg for 3 weeks and 10 mg for 4 weeks, n = 17)
Number of subjects: 57
Study: 16531889

Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic exercise (45 min, 5 days/week)
Number of subjects: 173

Group type: COMPARATOR
Intervention: Stretching control group
Number of subjects: 173
Study: 10538640

Group type: EXPERIMENTAL
Intervention: Nutrition education program with personal invitations, letters, and telephone reminders from peer educators encouraging attendance at three bimonthly nutrition sessions.
Number of subjects: 1528

Group type: EXPERIMENTAL
Intervention: Higher age, breast-feeding, and knowledge of the recommendation to eat five or more servings of fruits and vegetables daily.
Number of subjects: 1528

Group type: COMPARATOR
Intervention: Pregnant women who already had children.
Number of subjects: 1528

Group type: COMPARATOR
Intervention: Unmarried women compared with married women and blacks compared with nonblacks.
Number of subjects: 1528

Group type: COMPARATOR
Intervention: Reasons for nonattendance included withdrawal from WIC, moving, conflicting activities, negative feelings about nutrition education, and lack of transportation or child care.
Number of subjects: 1528
Study: 8878716

Group type: EXPERIMENTAL
Intervention: medroxyprogesterone acetate (MPA) 5 mg b.i.d.
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: dydrogesterone (DG) 10 mg b.i.d.
Number of subjects: 48
Study: 1725022

Group type: EXPERIMENTAL
Intervention: Ramipril, 10 mg once daily for 4 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 100
Study: 6838068

Group type: EXPERIMENTAL
Intervention: Clindamycin
Number of subjects: 39

Group type: COMPARATOR
Intervention: Penicillin
Number of subjects: 39
Study: 31113725

Group type: EXPERIMENTAL
Intervention: Sitafloxacin (100 mg/day for 3–10 days)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Garenoxacin (400 mg/day for 3–10 days)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Sitafloxacin
Number of subjects: 120

Group type: COMPARATOR
Intervention: Garenoxacin
Number of subjects: 120
Study: 29963797

Group type: EXPERIMENTAL
Intervention: Drug-coated balloon (DCB) angioplasty
Number of subjects: 187

Group type: COMPARATOR
Intervention: Conventional bypass surgery
Number of subjects: 187
Study: 26663712

Group type: EXPERIMENTAL
Intervention: Canagliflozin 300 mg
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Canagliflozin 100 mg
Number of subjects: 169

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 169
Study: 24844530

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioral therapy (iCBT) program in Manga format, delivered over six weeks with one lesson per week
Number of subjects: 381

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 381
Study: 22322156

Group type: EXPERIMENTAL
Intervention: Qlaira (estradiol plus dienogest) for 9 to 11 days before surgery
Number of subjects: 74

Group type: COMPARATOR
Intervention: Proliferative phase (cycle day 5‐7) without Qlaira
Number of subjects: 74
Study: 20334707

Group type: EXPERIMENTAL
Intervention: 2.2 g of marine n-3 PUFA daily for 12 weeks
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control oil daily for 12 weeks
Number of subjects: 92
Study: 18689157

Group type: EXPERIMENTAL
Intervention: Standard of care for hemophilia with inhibitors as per regional consensus and clinical guidelines.
Number of subjects: 3000
Study: 15639064

Group type: EXPERIMENTAL
Intervention: Drospirenone 3 mg / Ethinyl Estradiol 30 microg (DRSP/EE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Levonorgestrel 150 microg / Ethinyl Estradiol 30 microg (LNG/EE)
Number of subjects: 0
Study: 12717629

Group type: EXPERIMENTAL
Intervention: Fumagillin
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 10233563

Group type: EXPERIMENTAL
Intervention: Oral desmopressin
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 8942381

Group type: EXPERIMENTAL
Intervention: Hyaluronidase (25 IU/ml of mixture)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (standard mixture of local anaesthetic: 0.5% bupivacaine and 2% lignocaine in a 1:1 ratio without hyaluronidase)
Number of subjects: 50
Study: 1714670

Group type: EXPERIMENTAL
Intervention: CCK-9 100 pmol/kgh
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: CCK-9 500 pmol/kgh
Number of subjects: 18
Study: 31336633

Group type: EXPERIMENTAL
Intervention: Nitrate-rich beetroot juice (150 mL, 10.5 mmol nitrate)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (150 mL, 1 mmol nitrate)
Number of subjects: 24
Study: 30380279

Group type: EXPERIMENTAL
Intervention: McGRATH laryngoscope
Number of subjects: 37

Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 37
Study: 23171659

Group type: EXPERIMENTAL
Intervention: Online disease management intervention (n=193) including wirelessly uploaded glucometer readings, patient-specific reports, nutrition and exercise logs, insulin records, online messaging, nurse and dietitian support, and educational content.
Number of subjects: 415

Group type: COMPARATOR
Intervention: Usual care (n=189)
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Online disease management intervention (n=193)
Number of subjects: 415
Study: 22055636

Group type: EXPERIMENTAL
Intervention: Use of data and feedback processes by frontline staff
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Use of data and feedback processes by managers
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Information from mandated databases and feedback processes
Number of subjects: 126
Study: 20214224

Group type: EXPERIMENTAL
Intervention: BCAA granules (14.22 g/day)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 65
Study: 17145182

Group type: EXPERIMENTAL
Intervention: Letrozole (LET)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo (PLAC)
Number of subjects: 104
Study: 14722412

Group type: EXPERIMENTAL
Intervention: Whiplash subjects with mild, moderate, or severe pain and disability
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Moderate and severe whiplash groups
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Whiplash subgroups
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 80
Study: 11778799

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Sputum induction
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Visual analogue scores (VAS)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Chronic respiratory disease questionnaire (CRQ)
Number of subjects: 61
Study: 9302131

Group type: EXPERIMENTAL
Intervention: Intracavernous injection of 20 microg alprostadil alfadex (prostaglandin E1)
Number of subjects: 24

Group type: COMPARATOR
Intervention: 30-minute intravenous infusion of 20 microg alprostadil alfadex (prostaglandin E1)
Number of subjects: 24
Study: 8193494

Group type: EXPERIMENTAL
Intervention: Regular, aluminium‐adsorbed diphtheria‐tetanus vaccine
Number of subjects: 235

Group type: COMPARATOR
Intervention: Non‐adsorbed diphtheria‐tetanus vaccine
Number of subjects: 235